Medicare Enrolled
Dr. Amardeep Aulakh, D.O.
Internal Medicine · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aulakh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aulakh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aulakh
Dr. Amardeep Aulakh is an internal medicine specialist in Fresno, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aulakh performed 388,534 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aulakh received a total of $56,595 from 67 pharmaceutical and/or device companies across 572 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aulakh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 0% volume in CA
$56,595 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗388,534
Medicare services
Top 0% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
133,500 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
88,100 | $2 | $12 |
| Nivolumab injection (Opdivo) | 24,680 | $23 | $72 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
14,700 | $10 | $36 |
| Denosumab injection (Prolia/Xgeva) | 14,100 | $18 | $51 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
13,600 | $0 | $8 |
| Pembrolizumab injection (Keytruda) | 12,600 | $43 | $127 |
| Anti-nausea injection (aprepitant) | 11,050 | $1 | $11 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,375 | $0 | $1 |
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
7,680 | $0 | $2 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
7,524 | $27 | $88 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,080 | $36 | $119 |
| Paclitaxel chemotherapy injection | 6,709 | $0 | $8 |
| Injection, granisetron, extended-release, 0.1 mg | 6,100 | $5 | $20 |
| Iron infusion (Monoferric) | 3,000 | $16 | $61 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,974 | $0 | $8 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,950 | $33 | $225 |
| Bevacizumab-maly biosimilar injection, 10 mg An injection of bevacizumab-maly, a biosimilar medication, with a dosage of 10 mg. |
2,730 | $57 | $185 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,377 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,172 | $8 | $11 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,862 | $10 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,094 | $11 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,054 | $100 | $418 |
| Anti-nausea injection (Aloxi/palonosetron) | 970 | $1 | $10 |
| Iron level test | 632 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
632 | $9 | $22 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
625 | $13 | $35 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
614 | $24 | $87 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
526 | $110 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
457 | $142 | $558 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 355 | $3 | $14 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
346 | $21 | $64 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
345 | $19 | $48 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
342 | $2 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
340 | $53 | $197 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
335 | $2 | $12 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
330 | $1 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $67 | $286 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
294 | $1 | $2 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
273 | $15 | $38 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
247 | $1 | $9 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
228 | $261 | $853 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
188 | $1 | $9 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
187 | $55 | $194 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
181 | $14 | $37 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
168 | $17 | $61 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
159 | $9 | $24 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
142 | $6 | $16 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 142 | $20 | $53 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 138 | $285 | $898 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
132 | $1,363 | $4,921 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
123 | $60 | $154 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
118 | $13 | $47 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
115 | $24 | $84 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
106 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 106 | $165 | $594 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
105 | $3 | $9 |
| Injection, alteplase recombinant, 1 mg | 94 | $67 | $220 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 92 | $20 | $53 |
| PSA test (prostate cancer screening) | 87 | $18 | $46 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
87 | $27 | $90 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
83 | $12 | $32 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
78 | $50 | $145 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
72 | $96 | $252 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
63 | $104 | $628 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
62 | $4 | $11 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
58 | $78 | $375 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
55 | $61 | $222 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
48 | $264 | $943 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
47 | $27 | $94 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $140 | $521 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
31 | $16 | $42 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
29 | $106 | $480 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
29 | $4 | $14 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
28 | $47 | $171 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
28 | $51 | $149 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
27 | $49 | $248 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
25 | $3,634 | $9,504 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $126 | $450 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
16 | $60 | $193 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $20 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
38.2% high complexity
58.4% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$56,595
Total received (2018-2024)
Avg $8,085/year across 7 years
Top 3% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
572
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,587
2023
$7,380
2022
$24,958
2021
$8,440
2020
$3,186
2019
$3,354
2018
$1,690
Payments by company (2024)
Gilead Sciences, Inc.
$3,373
AstraZeneca Pharmaceuticals LP
$2,613
Celgene Corporation
$263
GlaxoSmithKline, LLC.
$192
ABBVIE INC.
$171
Exelixis Inc.
$154
Daiichi Sankyo Inc.
$146
Novartis Pharmaceuticals Corporation
$138
SEAGEN INC.
$100
E.R. Squibb & Sons, L.L.C.
$59
Ipsen Biopharmaceuticals, Inc
$55
Lilly USA, LLC
$54
BeiGene USA, Inc.
$36
Merck Sharp & Dohme LLC
$34
PharmaEssentia USA Corporation
$33
SOBI, INC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$26
Eisai Inc.
$25
SpringWorks Therapeutics, Inc.
$23
Sirtex Medical Inc
$20
PFIZER INC.
$16
SERVIER PHARMACEUTICALS LLC
$14
Agios Pharmaceuticals, Inc.
$14
Top 3 companies account for 82.4% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$24,131
AstraZeneca Pharmaceuticals LP
$8,568
Gilead Sciences, Inc.
$3,492
Karyopharm Therapeutics Inc.
$2,334
GENZYME CORPORATION
$2,059
Celgene Corporation
$2,038
Novartis Pharmaceuticals Corporation
$1,826
Epizyme, Inc.,
$1,268
E.R. Squibb & Sons, L.L.C.
$1,265
Rigel Pharmaceuticals, Inc.
$1,170
Seagen Inc.
$1,014
Seattle Genetics, Inc.
$1,010
Eisai Inc.
$970
GlaxoSmithKline, LLC.
$685
Amgen Inc.
$405
Exelixis Inc.
$376
Alexion Pharmaceuticals, Inc.
$284
Takeda Pharmaceuticals U.S.A., Inc.
$207
Kite Pharma, Inc.
$201
Novocure GmbH
$200
Genentech USA, Inc.
$179
Incyte Corporation
$177
ABBVIE INC.
$171
Sirtex Medical Inc
$169
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Cardinal Health 108, LLC
$152
Janssen Biotech, Inc.
$148
Regeneron Healthcare Solutions, Inc.
$135
Ipsen Biopharmaceuticals, Inc
$130
Pharmacyclics LLC, An AbbVie Company
$128
Foundation Medicine, Inc.
$113
BeiGene USA, Inc.
$102
Sobi, Inc
$101
SEAGEN INC.
$100
Merck Sharp & Dohme LLC
$93
TerSera Therapeutics LLC
$84
Pharmacyclics LLC, an AbbVie Company
$70
Lilly USA, LLC
$69
Dova Pharmaceuticals
$69
Astellas Pharma US Inc
$65
PFIZER INC.
$62
EMD Serono, Inc.
$57
PharmaEssentia USA Corporation
$47
AbbVie Inc.
$46
G1 Therapeutics, Inc.
$44
SOBI, INC
$43
Agios Pharmaceuticals, Inc.
$28
Merck Sharp & Dohme Corporation
$26
Myovant Sciences Inc.
$24
SpringWorks Therapeutics, Inc.
$23
Vertos Medical, Inc.
$21
MorphoSys, US Inc.
$20
Genmab U.S., Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
Stemline Therapeutics Inc.
$16
Shire North American Group Inc
$16
Pharmacosmos Therapeutics Inc.
$15
Apellis Pharmaceuticals, Inc.
$15
Heron Therapeutics, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
TESARO, Inc.
$15
Taiho Oncology, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Kyowa Kirin, Inc.
$14
Secura Bio, Inc.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 63.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · BELEODAQ · BESREMI · BLENREP · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Epkinly · FARYDAK · FOUNDATIONONE · FRUZAQLA · Fabhalta · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · INREBIC · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · Tavalisse · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · XGEVA · XPOVIO · YERVOY · Yescarta · ZEJULA · ZOLADEX · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
493
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aulakh is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aulakh experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Aulakh performed 133,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aulakh receive payments from pharmaceutical companies?
Yes. Dr. Aulakh received a total of $56,595 from 67 companies across 572 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aulakh's costs compare to other internal medicine physicians in Fresno?
Dr. Aulakh's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aulakh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fresno
Browse internal medicine physicians in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology